Empowering Biomarker Discovery in Parkinson’s Disease Research
In neurodegenerative disease research, the race is on to find reliable, non-invasive biomarkers that enable early diagnosis and intervention. One of the most compelling developments in recent years comes from the Nuffield Department of Clinical Neurosciences at Oxford University.